Yves Fradet

Yves Fradet

Université Laval

H-index: 86

North America-Canada

About Yves Fradet

Yves Fradet, With an exceptional h-index of 86 and a recent h-index of 44 (since 2020), a distinguished researcher at Université Laval, specializes in the field of Uro-Oncology, Tumor markers, Prognostic markers, Immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation

Salvage therapy for BCG failure with intravesical sequential gemcitabine and docetaxel in patients with recurrent NMIBC

The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids

The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression

Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study

Effects of concentrated long-chain omega-3 polyunsaturated fatty acid supplementation on quality of life after radical prostatectomy: a phase II randomized placebo-controlled …

CAnAdIAn BlAdder CAnCer ForUm 2023

Effects of omega‐3 supplementation on psychological symptoms in men with prostate cancer: Secondary analysis of a double‐blind placebo‐controlled randomized trial

Yves Fradet Information

University

Position

___

Citations(all)

28689

Citations(since 2020)

10787

Cited By

22680

hIndex(all)

86

hIndex(since 2020)

44

i10Index(all)

288

i10Index(since 2020)

158

Email

University Profile Page

Université Laval

Google Scholar

View Google Scholar Profile

Yves Fradet Skills & Research Interests

Uro-Oncology

Tumor markers

Prognostic markers

Immunotherapy

Top articles of Yves Fradet

Title

Journal

Author(s)

Publication Date

A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation

Communications Medicine

Karine Robitaille

Marie-Hélène Guertin

Afshin Jamshidi

Hui Wen Xu

Hélène Hovington

...

2024/3/22

Salvage therapy for BCG failure with intravesical sequential gemcitabine and docetaxel in patients with recurrent NMIBC

Canadian Urological Association Journal

Charles-Antoine Garneau

Nathalie Marcotte

Louis Lacombe

Yves Fradet

Vincent Fradet

...

2024/2

The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids

Nature Communications

Gabriel Lachance

Karine Robitaille

Jalal Laaraj

Nikunj Gevariya

Thibault V Varin

...

2024/4/23

The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression

The Journal of Clinical Investigation

Camille Lafront

Lucas Germain

Gabriel H Campolina-Silva

Cindy Weidmann

Line Berthiaume

...

2024/4/16

Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study

Cancers

Mame-Kany Diop

Oscar Eduardo Molina

Mirela Birlea

Hélène LaRue

Hélène Hovington

...

2023/4/9

Effects of concentrated long-chain omega-3 polyunsaturated fatty acid supplementation on quality of life after radical prostatectomy: a phase II randomized placebo-controlled …

Nutrients

Hanane Moussa

Karine Robitaille

Jean-François Pelletier

Roxane Tourigny

Yves Fradet

...

2023/3/11

CAnAdIAn BlAdder CAnCer ForUm 2023

CUAJ

Alain Bergeron

Valérie Picard

Marjorie Besançon

Lisa D MacDonald

Kabir Mody

...

2023/3

Effects of omega‐3 supplementation on psychological symptoms in men with prostate cancer: Secondary analysis of a double‐blind placebo‐controlled randomized trial

Cancer Medicine

Josée Savard

Hanane Moussa

Jean‐François Pelletier

Pierre Julien

Louis Lacombe

...

2023/10

Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic–mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer

Molecular Oncology

Kevin Gonthier

Cindy Weidmann

Line Berthiaume

Cynthia Jobin

Aurélie Lacouture

...

2023/10

Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up

Annals of Oncology

AV Balar

DE Castellano

P Grivas

DJ Vaughn

T Powles

...

2023/3/1

High infiltration of CD209+ dendritic cells and CD163+ macrophages in the peritumor area of prostate cancer is predictive of late adverse outcomes

Frontiers in Immunology

Oscar Eduardo Molina

Hélène LaRue

David Simonyan

Hélène Hovington

Bernard Têtu

...

2023/6/26

UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways

Cancer Letters

Louis Lacombe

Hélène Hovington

Hervé Brisson

Sadia Mehdi

Déborah Beillevaire

...

2023/1/28

Analysis of sex-based differences to Bacillus Calmette-Guérin for non-muscle invasive bladder cancer

Urologic Oncology: Seminars and Original Investigations

Jonathan Fadel

David Simonyan

Vincent Fradet

Michele Lodde

Louis Lacombe

...

2022/12/1

Relations entre habitudes de vie, microbiote intestinal et risque de cancer de la prostate

Revue d'Épidémiologie et de Santé Publique

P Mapepe

G Lachance

A Jamshidi

S Castonguay-Paradis

A Veilleux

...

2022/8/1

A natural polyphenol exerts antitumor activity and circumvents anti–PD-1 resistance through effects on the gut microbiota

Cancer Discovery

Meriem Messaoudene

Reilly Pidgeon

Corentin Richard

Mayra Ponce

Khoudia Diop

...

2022/4/1

Effects of omega-3 fatty acids supplementation on perioperative blood loss and complications after radical prostatectomy

Clinical Nutrition ESPEN

Samuel Fradet

Jean-François Pelletier

Narcisse Singbo

Louis Lacombe

Paul Toren

...

2022/2/1

Perception and satisfaction of patients after telemedicine urology consultations: A matched analysis with physicians’ perspective

Canadian Urological Association Journal

Bruno Turcotte

Lynda Bélanger

Anne-Sophie Blais

Annie-Claude Blouin

Stéphane Bolduc

...

2022/10

Multiple metabolic pathways fuel the truncated tricarboxylic acid cycle of the prostate to sustain constant citrate production and secretion

Molecular Metabolism

Lilianne Frégeau-Proulx

Aurélie Lacouture

Line Berthiaume

Cindy Weidmann

Mario Harvey

...

2022/8/1

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial

The Lancet Oncology

Matthew R Smith

Howard I Scher

Shahneen Sandhu

Eleni Efstathiou

Primo N Lara

...

2022/3/1

Sex steroid modulation of macrophages within the prostate tumor microenvironment

American Journal of Clinical and Experimental Urology

Zohra Berrehail

Clovis Boibessot

Typhaine Gris

France-Hélène Joncas

Fanny Gaignier

...

2022

See List of Professors in Yves Fradet University(Université Laval)